로딩 중…
StockDiggingStockDigging

DRGEM Corporation

263690· KOSDAQ
₩5,070+1.00%
2026-08-04

Financials

Valuation Metrics

DRGEM Corporation's Market Cap is ₩574B. At end of 2025 it was ₩605B. Ranked #1640 of 2,436 in KR market (top 67%), #975 of 1,649 on KOSDAQ (top 59%), #66 of 96 in Health Care Equipment & Services (top 69%) by Market Cap.

Investment Metrics(as of 2026-08-04)

MetricValue
Size
Market Cap57.42B KRW
Revenue106.74B KRW
Net Income9.61B KRW
Total Assets128.48B KRW
Net Assets94.36B KRW
Employees278
Value
P/E5.98x
P/B0.61x
PEG0.02x
P/S0.54x
EV/EBITDA6.06x
FCF Yield16.52%
Profitability
ROE10.18%
ROA7.48%
Op. Margin9.31%
Revenue Growth17.10%
Earnings Growth245.61%
Financial Health
Debt Ratio136.16%
Total Debt20.00B KRW
FCF9.48B KRW
Cash17.14B KRW
Current Ratio3.20x
Net Debt/EBITDA0.29x
Dividend
Div. Yield3.55%
Div. Growth11.25%
Performance
1Y Return-7.14%
1M Return0.60%
From 52W High-28.79%
1Y MDD-27.04%
Trading
Volume17,777 shares
Foreign Own.15.67%
Per Share
EPS848 KRW
BPS8,661 KRW

Company Info

CEO 박정병
Employees 278
Founded 2003
HQ 경기도 광명시, KR

DRGEM, established in 2003 and listed on KOSDAQ in 2018, researches, develops, manufactures, and sells X-ray imaging devices for patient diagnosis. The company holds subsidiaries DRGEM America Inc. and Weihai Drgem Medical Equipment Company Limited. It sells various diagnostic analog and digital X-ray imaging devices through 250 dealers in 120 countries worldwide. DRGEM is headquartered in Gwangmyeong-si, Gyeonggi-do.